INTRODUCTION
============

The paracellular seal between epithelial cells is formed by continuous cell--cell adhesive rows of the claudin (cldn) family proteins ([@B10]). Although several different integral membrane proteins contribute to this seal, including occludin ([@B9]), tricellulin ([@B15]), and junctional adhesion molecules (JAMs; [@B21]), cldns are the critical components that regulate paracellular ionic and solute size selectivity ([@B37]; [@B13]). Claudins are the primary constituents of the network of strands seen in freeze-­fracture electron microscopy (FFEM) that forms a continuous seal around the apicolateral pole of epithelial cells ([@B10]). The FFEM strands formed by cldns are stabilized by adhesive interactions between extracellular domains in the paracellular space; this interaction then facilitates lateral polymerization into strands ([@B24]; [@B19]). The cytoplasmic amino acid sequence of most cldns ends with a C-terminal PDZ binding motif, which interacts with the first PDZ domain of the tight junction scaffolding proteins zonula occludens (ZO) 1--3 ([@B16]). The ZO proteins directly bind actin ([@B7]) and numerous actin-regulating proteins ([@B27]) and thus are hypothesized to form a stabilizing link between the seal and the cytoskeleton.

In spite of the well-demonstrated in vitro binding between cldns and ZO-1 and between ZO-1 and actin, the in vivo relevance, nature, and regulation of these interactions remain unclear. When expressed in epithelial or endothelial cells, cldns lacking the PDZ binding motif still localize to tight junctions ([@B28]). ZO-1 knockout ([@B34]) in Madin--Darby canine kidney (MDCK) cells results in only minor effects on cldn and actin organization, although double knockdown of ZO-1 and ZO-2 decreases tight junction localization of some but not all cldns and also results in accumulation of apical actin ([@B8]). In contrast, ZO-1 knockout/ZO-2 knockdown does result in loss of tight junction cldn organization ([@B35]), but in these cells, adherens junction organization is also compromised ([@B40]).

It has been known for many years that disruption of the actin cytoskeleton results in loss of tight junction organization ([@B22]), but because other cell junctions are disrupted as well, it is difficult to isolate the specific contributions of actin to tight junction organization. In addition, fluorescence recovery after photobleaching (FRAP) analysis of tight junction proteins demonstrates very different recovery kinetics for cldns, ZO-1, and actin, suggesting that their interactions at the junction are not static but are coupled in a highly dynamic manner ([@B33]).

Tight junction contacts must be both sufficiently stable to maintain a continuous seal and sufficiently dynamic to allow adaption of this seal to the continuous motion relative to adjacent cells. Both FRAP and live-cell imaging studies ([@B38]; [@B31]) demonstrate this dynamic nature of tight junction contacts. However, the small size and the geometry of intact epithelial junctions limit our ability to dissect microscopically the influence of specific protein--protein interactions in modulating the balance between stable and dynamic behavior. [@B29]) demonstrated the utility of expressing green fluorescent protein (GFP) cldns in fibroblasts to study cldn strand dynamics. We turned to a similar reductionist system, using structured illumination microscopy (SIM; [@B14]) for live-cell imaging of tagged cldns, ZO-1, actin, and occludin (ocln) in fibroblasts to directly investigate the role of ZO-1 and association with the actin cytoskeleton in cldn behavior.

RESULTS
=======

Expression of GFP Cldn2 in Rat-1 fibroblasts results in tight junction--like strands at cell--cell contacts
-----------------------------------------------------------------------------------------------------------

Immunofluorescence imaging of Rat-1 fibroblasts demonstrated that endogenous ZO-1 is found at well-defined N-cadherin--based cell contacts, where actin filaments also accumulate ([Figure 1A](#F1){ref-type="fig"}); these fibroblasts are flat, and the overlapping cell contacts are amenable to high-resolution imaging in the *xy*-plane. Expression of N-terminally tagged GFP cldn2 in these cells results in the formation of strand patches similar to those described by [@B29]). High-resolution confocal analysis of transfected cells using the Zeiss Airyscan detector demonstrated that these patches are mainly found at the cell periphery where cells overlap ([Figure 1B](#F1){ref-type="fig"}) and consist of both tight, complex strand networks ([Figure 1B](#F1){ref-type="fig"}, arrowhead) and loose associated strands ([Figure 1B](#F1){ref-type="fig"}, arrow). As previously suggested ([@B29]), strand patches were composed of paired strands from adjoining cells; we confirmed this by coculture of cells expressing either GFP or mCherry cldn2 ([Figure 1C](#F1){ref-type="fig"}), which showed complete strand overlay from the contiguous cells. That cldn strand patches formed exclusively between two cells is consistent with the primary requirement for transcellular interaction to promote strand formation ([@B24]; [@B19]).

![Cldns form strand patches when expressed in fibroblasts. (A) Endogenous ZO-1 in Rat-1 (top left) fibroblasts colocalizes with N-cadherin (top right) and a subset of actin (bottom left and merge) at cell contacts; bar, 20 μm. (B) Stable expression of GFP-tagged cldn2 results in strand patches that are associated with the cell borders (arrowhead); some patches have loose collections of cldn strands (arrow); bar, 10 μm. (C) Coculture of cells expressing GFP cldn2 (left) and mCherry cldn2 (middle) confirms that cldn strand patches form only between two cldn-expressing cells (merge); bar, 4 μm. (D) SIM analysis of GFP cldn2 strand patch shows a mixture of well-separated and condensed strands; bar, 2 μm. (E) Plot profiles of well-separated areas shows fluorescence intensity of single strand (purple) is half that of doubled strand (green).](524fig1){#F1}

When visualized by SIM, GFP cldn2 forms complex strand networks ([Figure 1D](#F1){ref-type="fig"}) reminiscent of networks seen in FFEM; we observed similar strand organization in cells expressing GFP cldn1 and cldn11 (Supplemental Figure S1). Line profile analysis of the images of well-separated strands ([Figure 1D](#F1){ref-type="fig"}, magenta and green lines) showed that the fluorescence intensity across stands increased in unitary steps ([Figure 1E](#F1){ref-type="fig"}), which suggested that it was possible to recognize single, doubled, and occasionally tripled (unpublished data) strands, although the strand density in many patch areas was too high to allow further resolution. We assume that the well-separated fluorescent strands of unit fluorescence intensity correspond to individual FF strands visualized by EM ([@B29]). To simplify interpretation of strand behavior, most of the subsequent studies were carried out on relatively loosely packed strand patches.

Confocal analysis of transfected GFP cldn2 in Rat-1 cells revealed the formation of strand patches that partially colocalized with endogenous ZO-1 at cell--cell contacts ([Figure 2A](#F2){ref-type="fig"}, top). In contrast, although transfection of similarly tagged cldn2 with the PDZ binding motif deleted (−3) resulted in the formation of strand patches indistinguishable from those formed by full-length cldn2, these patches did not colocalize with ZO-1 ([Figure 2A](#F2){ref-type="fig"}, bottom). There was no clear difference in ZO-1 distribution in cells expressing cldn2 containing or lacking the PDZ binding motif. Because it was possible that the fusion of GFP to the very short N-terminal intracellular sequence of cldn might hinder interaction with ZO-1, we also made a construct with the N-terminal GFP separated from cldn2 by a 15--amino acid (three GGGGS repeats) flexible linker ([@B4]). Pull-down assays ([Figure 2B](#F2){ref-type="fig"}) using HEK cell lysate from cells separately transfected with myc-tagged N-terminal half of ZO-1 containing the PDZ domains (ZNA; [@B7]) and GFP alone, N-terminally tagged GFP cldn2, N-terminally tagged GFP cldn2(−3), and N-­terminally tagged GFP cldn2 with the Linker domain between GFP and cldn2 demonstrated binding between ZNA and GFP cldn2 and GFP Linker cldn2 but not between ZNA and GFP alone or GFP cldn2(−3). The presence of the linker improved binding of cldn2 to ZO-1 about threefold; however, the colocalization with ZO-1 and behavior of GFP cldn2 with and without the linker region were similar.

![Interaction of cldn with ZO-1 affects localization and strand dynamics. (A) Both N-terminal GFP cldn2 (top) and cldn2(−3) (bottom) form strand patches in fibroblasts, but the PDZ binding motif is required for ZO-1 colocalization; bar, 10 μm. (B) Pull down of cldn2 constructs with myc-tagged ZO-1 (ZNA) (lysate; left) demonstrates that GFP linker cldn2 binds ZO-1 better than GFP cldn2, whereas GFP cldn2(−3) fails to bind ZNA (right). (C) Frames from live-cell imaging of GFP Linker cldn2 (top; Supplemental Figure 2CVideo1) and GFP Cldn2(−3) (bottom; Supplemental Figure 2CVideo2) demonstrates increased mobility in cldn2(−3) strand patches; yellow outline, patch shape at the start and end of 10-min movies (bar, 2 μm). (D) Variation in strand patch areas over 10 min is significantly greater in (−3)-expressing cells than in those expressing GFP linker cldn2 (*p* \> 0.001; *F* test to compare variances).](524fig2){#F2}

GFP Cldn2 strand dynamics is constrained by interaction with ZO-1
-----------------------------------------------------------------

[@B29]) demonstrated the dynamic behavior of strand patches using cldns tagged on the C-terminus with GFP, which blocked interaction with ZO-1. Because ZO-1 binding might be likely to anchor cldns at the junction, we used live-cell imaging to compare cldn dynamics in cells stably expressing GFP Linker cldn2 with those expressing GFP cldn(−3). As expected, we found that cldn strand patches in cells expressing GFP cldn2(−3) were much more mobile that strand patches composed of GFP Linker cldn2; we quantified this by measuring strand patch area at the start of imaging and 10 min later ([Figure 2C](#F2){ref-type="fig"}, top, and Supplemental Figure 2C Video1). All strand patches translocated with the cells as the cells moved. However, the patch area and shape were relatively constant in cells expressing GFP Linker cldn2 but fluctuated in cells expressing GFP cld2(−3) This meant that the final patch shape and size were often different in these cells compared with the initial organization ([Figure 2C](#F2){ref-type="fig"}, bottom, and [Supplemental Figure 2C](#F2){ref-type="fig"}Video2; compare yellow outlines from the start of imaging). The behavior of the strand patches over time was quantified by comparing the variance in patch sizes in cells expressing GFP Linker cldn2 and GFP cldn2(−3). The small variance in area in cldn strands that could bind ZO-1 compared with the significantly larger variance in those that could not was consistent with the hypothesis that binding to ZO-1 is likely to stabilize cldn strands at the tight junction. The overall strand dynamics (independent of ability to interaction with ZO-1) was not affected by administration of the Rho kinase inhibitor Y27632, the Arp2/3 inhibitor CK666, or the administration of blebbistatin (unpublished data).

Phosphomimetic substitution of Cldn2 Y224 results in increased strand mobility
------------------------------------------------------------------------------

We recently showed that cldn2 interaction with PDZ1 of ZO-1 was stabilized by a tyrosine at --6 (Y224) in the cldn tail ([@B23]) and that this site can be phosphorylated in vivo ([@B39])*.* Introduction of cldn2 with a phosphomimetic Y224E mutation strongly altered the transepithelial resistance and charge selectivity of MDCK monolayers ([@B23]). To determine whether the phosphorylation of this residue might regulate cldn strand behavior, we examined strand dynamics in cells stably expressing GFP cldn2 with and without the phosphomimetic mutation Y224E. We first confirmed by pull-down assays using lysate from transfected HEK cells that GFP Linker cldn2 Y224E had greatly reduced affinity for ZNA compared with wild-type GFP Linker cldn2 ([Figure 3A](#F3){ref-type="fig"}). We then compared live-cell behavior of cells expressing GFP Linker cldn2 with and without the Y224E substitution and showed that, like cldn2(−3), strand patches composed of GFP Linker cldn2 Y224E showed larger variations in strand patch size compared with those of wild-type GFP Linker cldn2 ([Figure 3B](#F3){ref-type="fig"}, Supplemental Figure 3FVideo3, and Supplemental Figure 3FVideo4; quantified in [Figure 3C](#F3){ref-type="fig"}). The different behavior of the linker-containing constructs without and with the Y224E mutation suggests that tyrosine phosphorylation at the cldn2 −6 position might be a physiological mechanism for regulation of interaction with ZO-1 and thus changes in cldn strand behavior.

![Cldn2 Y224 stabilizes interaction with ZO-1. (A) Pull down of GFP cldn2(Y224E) shows only weak interaction with myc-tagged ZNA compared with wild-type cldn2. Imaging of strand patches (B; Supplemental Figure 3BVideo3 and Supplemental Figure 3BVideo4; bar, 2 μm) and quantification of patch area variation (C) demonstrate that ZO-1 interaction constrains wild-type but not mutant cldn2 strand patch mobility (*p* = 0.0132; F test to compare variances).](524fig3){#F3}

GFP Cldn2 is associated with actin through binding to ZO-1
----------------------------------------------------------

ZO-1 binds to actin and many actin-binding proteins ([@B7]; [@B27]) and thus might constrain cldn strand dynamics by cross-linking cldn to the actin cytoskeleton. If this were true, cldn2 that could interact with ZO-1 might be oriented along actin filaments, but cldn2 strand patches that could not bind ZO-1 would not align with actin. We used the ImageJ plug in FibrilTool ([@B3]) to test whether there were differences between GFP cldn2 with or lacking the PDZ binding motif and actin filaments by comparing relative orientation and anisotropy of GFP and actin signals. [Figure 4A](#F4){ref-type="fig"} (top) shows two examples of the orientation of the GFP and actin signals as determined by FibrilTool in cells expressing GFP Linker cldn2; the correlation of the orientation of GFP and actin in this cell clone ([Figure 4B](#F4){ref-type="fig"}) was calculated to be 0.959. In contrast, the correlation between GFP and actin was much weaker in cells expressing GFP cldn2(−3) ([Figure 4A](#F4){ref-type="fig"}, bottom); the correlation coefficient was 0.450 for cells expressing this construct ([Figure 3C](#F3){ref-type="fig"}). To verify that this interaction was dependent on ZO proteins and not on other PDZ domain--containing proteins, we made clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9--mediated knockout (KO) ZO-1/2 Rat-1 cell lines ([Figure 4D](#F4){ref-type="fig"}). Single KO of ZO-1 or ZO-2 had little effect on GFP cldn2 behavior (unpublished results), but double ZO-1/2 KO resulted in formation of fewer GFP cldn2 strand patches and sparse, scattered strands that had no clear association with the underlying actin cytoskeleton ([Figure 4E](#F4){ref-type="fig"}); the correlation coefficient for actin and GFP was --0.1534 ([Figure 4F](#F4){ref-type="fig"}). Unsurprisingly, the anisotropy of the GFP Linker cldn2 was significantly higher than that of GFP cldn2(−3) or the GFP Linker cldn2 expressed in the ZO-1/2 double-KO cells. These findings are consistent with a role for ZO-1 in linking and orienting cldns to the actin cytoskeleton.

![Cldn2 associates with the actin cytoskeleton through interaction with ZO-1/2. (A) FibrilTool (ImageJ) was used to analyze relationships between cldn2 and actin. There was higher correlation between the orientation of the linker construct (top; B) and actin than that of the (−3) construct and actin (bottom; bar, 2 μm; C). (D) KO of ZO-1/2 resulted in loss of correlation between GFP Linker cldn2 and actin (E, F; bar 2 μm). (G) Analysis of anisotropy of GFP cldns shows significantly higher anisotropy values for Linker construct compared with (−3) or Y224E cldn2.](524fig4){#F4}

To better understand the relationships between actin, endogenous ZO-1, and GFP Linker cldn2, we compared their localization using SIM. This analysis demonstrated a very close relationship between the ZO-1 signal and that of the actin filaments ([Figure 5](#F5){ref-type="fig"}), which is particularly evident in the ZO-1/actin overlay (bottom, middle). The GFP Linker cldn2 is associated with the ZO-1 signal, but it also forms a free network of strands that appear to be only intermittently associated with ZO-1 (arrow, top, middle). This is easier to see in a skeletonized image of the GFP cldn2/ZO-1 overlay (compare top two right images). This loose network of strands could be due in part to a mismatch in the levels of expression of scaffolding and cldn proteins, but it was a common feature of the claudin strand patches in multiple cell lines at every cldn expression level. The immunofluorescence signal for the GFP cldns was always continuous, whereas those for ZO-1 and actin was always intermittent (endogenous or tagged), consistent with intermittent and irregular rather than continuous and stoichiometric tethering of strands to ZO-1 and ZO-1 to actin.

![Colocalization of GFP cldn2 with endogenous ZO-1 and actin demonstrates good correlation between ZO-1 and actin localization (bottom, middle), whereas GFP cldn2 is associated with ZO-1 and actin but also forms independent loops (arrow; top right, skeletonized image of middle; bar, 1.5 μm).](524fig5){#F5}

Coexpression of ocln with GFP-cldn2 alters occludin FRAP recovery but not strand dynamics
-----------------------------------------------------------------------------------------

[@B33]) used FRAP analysis to demonstrate differential recovery rates and mobile fractions for cldn1, ocln, and ZO-1 in epithelial cells. Because Rat-1 fibroblasts might differ from epithelial cells in how they control dynamics of these proteins, we first documented as a baseline the FRAP parameters of GFP ZO-1, GFP ocln, and GFP cldn2 with and without the PDZ binding motif or containing the Y224E mutation. Prebleach and postbleach images of representative areas for each of these proteins ([Figure 6A](#F6){ref-type="fig"}) demonstrates quick recovery for GFP ZO-1 and ocln but no measurable recovery of cldn2, cldn2(−3), or cldn2 Y224E. Overall these results are very similar to those described in epithelial cells. The lack of recovery of cldn that cannot bind ZO-1 was previously shown in fibroblasts by [@B29]). Second, we asked whether we could detect interactions between the transfected cldns and ZO-1 by performing FRAP analysis on cell lines stably coexpressing GFP ZO-1 or GFP ocln with mCherry cldn2. We found that there was no effect of coexpression with cldn on the kinetics of ZO-1 recovery ([Figure 6B](#F6){ref-type="fig"}, top), but that, in contrast, coexpression of cldn2 with ocln significantly decreased mobility of GFP ocln ([Figure 6B](#F6){ref-type="fig"}, bottom). These results are quantified in [Figure 6C](#F6){ref-type="fig"} and the mobile fraction and recovery *T*~1/2~ ([Figure 6D](#F6){ref-type="fig"}) calculated from the recovery curves. These results are consistent with the finding that ocln can be incorporated into cldn strands in fibroblasts ([@B10]). However, in spite of the interaction between ocln and cldn2, there was no clear effect of coexpression of ocln with cldn2 on strand patch mobility ([Figure 6E](#F6){ref-type="fig"}).

![Tight junction proteins differ in FRAP dynamics. (A) GFP ZO-1, ocln, and cldn2 (wild type, (−3), and Y224E) show distinct FRAP behaviors in Rat-1 cells. Images before and at the indicated time points after photobleaching. Brackets indicate bleach regions. (B) FRAP behavior after coexpression of GFP ZO-1 and ocln with mCherry cldn2; yellow signal, region of colocalization. (D) Mobile fraction and *t*~1/2~ of recovery for each protein calculated from the recovery curves in C; *n* = 10 for each cell line. Error bars represent SEM. (E) Analysis of strand patch size changes over 10 min in cells coexpressing ocln with cldns, showing no difference between patch area; *F* test to compare variances.](524fig6){#F6}

Unexpectedly, SIM images of Rat-1 cells coexpressing GFP cldn2 and Halo-tagged ocln ([Figure 7](#F7){ref-type="fig"}) showed nonuniform incorporation of ocln into the cldn2 strands. The insets in [Figure 7](#F7){ref-type="fig"} highlight that although there were many patches of occludin along strands, Halo ocln clearly concentrates at strand ends and strand-to-strand junction points. The molecular organization of cldns at sites at which two strands join is unknown, but the accumulation of ocln at these sites suggested that they might be structurally specialized or disorganized in a way that promotes interaction with ocln.

![Ocln colocalizes with cldn2 but concentrates at strand ends and junction points. Immunofluorescence colocalization of GFP cldn2 and Halo ocln stably expressed in Rat-1 cells (bar, 5 μm); right, enlargements of the indicated areas, showing Halo ocln concentration at strand junction points.](524fig7){#F7}

GFP cldn strand breaks occur primarily at branch points; free ends show a propensity to reanneal
------------------------------------------------------------------------------------------------

Although [@B29]) demonstrated that individual strands within a cldn strand patch break and reanneal, because they used cldn that could not interact with ZO-1 in these experiments, it was unclear whether this behavior would be modified by interaction with ZO-1. To test whether ZO-1 binding affected strand breaks, we counted the number of breaks in equivalent-sized strand patches from cells expressing GFP cldn2 with or without the PDZ binding motif. Breaks were relatively rare (approximately two breaks per average patch size of 5 μm^2^), but we found that although the overall strand patch area is stabilized by interaction with ZO-1, the ability to interact with ZO-1 had no apparent effect on the pattern or number of strand breaks or joins ([Figure 8A](#F8){ref-type="fig"}). However, it was clear that the majority of breaks occur at sites where two strands join at a T-junction (91%, *n* = 57); this pattern can be observed in still images in [Figure 8B](#F8){ref-type="fig"} and time-lapse images in Supplemental Figure 8BVideo5; arrows mark the sites of breaks and joins. Often the T-junction will break, reanneal, and rebreak at another arm of the T ([Figure 8B](#F8){ref-type="fig"}, top, arrows), suggesting that the junction point is more fragile at all join points, not just at the site at which the strand makes a 90^o^ end-to-side attachment with a straight strand. In some cases, a strand end appears to translocate along a straight strand ([Figure 8C](#F8){ref-type="fig"}, top, and [Figure 8B](#F8){ref-type="fig"}Video6). Occasionally, strand breaks occur midstrand ([Figure 8C](#F8){ref-type="fig"}, bottom, and [Figure 8C](#F8){ref-type="fig"}Video6); in many cases (arrows), the breaks reanneal almost immediately. Strand ends behave as if their structure is unstable, in that they often quickly join and rebreak. Often, free ends (Supplemental Figure 8CVideo6) behave as if they are guided back to reanneal, as if there were as-yet-undetermined influences promoting strand continuity. Strand breaks and rejoins are not associated with obvious changes in the underlying actin cytoskeleton ([Figure 8D](#F8){ref-type="fig"}, arrows), which was consistent with our finding that breaks and reannealing behavior are not affected by the ability of the GFP cldn2 construct to bind ZO-1.

![Cldn strands break and reanneal, especially at T-junctions. (A) Frequency of cldn strand breaks in arbitrarily defined 5-μm strand patch areas is similar among GFP Linker cldn2, GFP cldn2(−3), and GFP cldn2^Y224E^. (B) Strand network reorganization in stills from live-cell imaging; arrows point to breaks (Supplemental Figure 8BVideo5). (C) Small still-image series shows apparent translocation of a strand end along another strand (top; Supplemental Figure 8CVideo6) and a breaking and rapid reannealing (bottom; Supplemental Figure 8CVideo7). (D) Immunofluorescence imaging of cldn and F-tractin (Supplemental Figure 8CVideo8) does not suggest association of breaks with changes in underlying actin; arrows point to breaking and reannealing (bar, 5 μm). Time in seconds.](524fig8){#F8}

Newly synthesized cldn is added to strands focally and preferentially at strand junction points
-----------------------------------------------------------------------------------------------

The behavior of joins and breaks in the cldn strands suggested that these sites were less stable than the linear strands, and we speculated they might be sites for addition of newly synthesized cldns. To test this possibility, we stably expressed SNAP-tagged cldn2 in Rat-1 cells and used a pulse-chase-pulse protocol ([Figure 9A](#F9){ref-type="fig"}) to distinguish between old and newly synthesized protein. SNAP tags were covalently labeled with one fluorescent dye, unlabeled tags were blocked with an excess of blocking reagent, and then, after 2--8 h, newly synthesized SNAP-tagged cldns were labeled with a second fluorescent dye. After 3 h ([Figure 9B](#F9){ref-type="fig"}), most cldn strands were labeled with the first fluorescent dye, but there was clear focal addition of new clds. Higher magnification of strands at this early time point ([Figure 9C](#F9){ref-type="fig"}) showed that the second fluorescent label was concentrated at strand ends and T-junctions (arrows), although new label did occasionally appear along strands. Incubation with the second fluorescent label at 5 and 8 h after chase ([Figure 9B](#F9){ref-type="fig"}) demonstrated that the label addition remained focal and discontinuous, although incorporation of new cldn increased as incubation time increased. These results suggest that ([Figure 9D](#F9){ref-type="fig"}) addition of new cldns does not involve a molecular-level replacement of claudins along the strands but instead focal addition at special sites, such as breaks or ends. We were unable to see new cldn addition in live-cell imaging, but the sites of the appearance of new label were the same areas that were most dynamic in terms of breaking and reannealing in the earlier network analysis studies.

![Pulse-chase-pulse experiments indicate new cldn addition to strands is focal and concentrates at sites of strand breaks. (A) Diagram of pulse-chase-pulse method. (B) Immunofluorescence images of SNAP-tagged cldn labeled with TMR only (left), TMR, block, and after 3, 5, and 8 h with SNAP- Cell 647 (middle three consecutive panels), and with SNAP-Cell 647 only (right; bar, 5 μm). (C) Higher-magnification images from 3-h pulse-chase-pulse experiment; arrows point to sites of addition of newly synthesized cldns. (D) Models for possible mechanisms of cldn addition to new strands.](524fig9){#F9}

DISCUSSION
==========

Formation and regulation of the tight junction seal are highly dependent on the state of perijunctional actin, and thus it is important to understand how cldn strands are coupled to actin and how these interactions are physiologically regulated and altered in pathology. We developed a reductionist model in fibroblasts to manipulate and visually study these links. Expression of cldns in tight junction--null fibroblasts results in flattened, spread strand patches that are accessible for superresolution live-cell imaging. This is not the case with intact epithelial tight junctions, where cldn strands are closely packed and arranged vertically on the apicolateral cell membrane; this configuration is difficult to image even with superresolution techniques, which have lower *z*-axis than *xy*-axis resolution ([@B30]). Fibroblast cell models to study cldns were used previously to investigate cldn--cldn interactions ([@B6]) and dynamic behavior ([@B29]). Our use of a similar Rat-1 cell expression system allowed us to address the apparent contradiction between the concept that ZO-1 acts as a rigid molecular scaffold, linking clds to the actin cytoskeleton, and the FRAP findings that ZO-1, cldns, and actin have very different motilities, suggesting that interactions among these components are intermittent and highly dynamic.

As mentioned previously, the importance of ZO-1 and ZO-2 as cldn scaffolds was demonstrated in mouse mammary epithelial cells, where ZO-1 knockout coupled with ZO-2 knockdown resulted in loss of cldn localization to cell contacts ([@B35]). However, cldns lacking the PDZ binding motif localize appropriately to intact junctions ([@B28]), suggesting that targeting is not solely dependent on PDZ interactions. In addition, cldns lacking not only the PDZ binding motif but almost the entire C-terminal intracellular domain can still form strand patches in L-cell fibroblasts ([@B11]), so that strand organization does not depend on scaffold interactions. In the present study, we find strand patches made from cldns containing or lacking the PDZ binding motif form indistinguishable strand patches but that binding to ZO-1 (and ZO-2) has profound effects on strand movements. The finding that ZO-1 constrains the mobility of strands within patches is a direct demonstration that ZO-1 does not just localize to but also stabilizes tight junction strands. In addition, we found that mutation of cldn2 tyrosine 224, which contributes to PDZ-dependent ZO-1 binding ([@B23]), both decreases affinity for ZO-1 and fails to restrain cldn strand mobility. This tyrosine is shared by 9 of 23 identified human cldns, and phosphorylation of cldn2 tyrosine 224 was previously identified in mass spectrometry analysis of cldn2 phosphopeptides ([@B39]). Thus this finding suggests a potential tyrosine kinase regulatory mechanism for altering the stability of the strands.

Although it has long been speculated that ZO-1 forms a link between cldns and the actin cytoskeleton, the mutual dependence among these proteins is not well defined. For example, [@B18]) showed that disruption of the actin cytoskeleton in primary cultured hepatocytes with an actin-depolymerizing agent resulted in displacement of occludin and ZO-1, but the tight junction strand organization was unaffected. Similarly, [@B32]) demonstrated that actin depolymerization with latrunculin A resulted in changes first in occludin and then in cldn1 and finally ZO-1 localization; disruption of each of these proteins had distinct kinetics. The same group later showed that inhibition of myosin light chain kinase stabilizes junctional ZO-1 without affecting cldn1 or actin dynamics ([@B42]). These results suggest a complex relationship between junctional actin and the transmembrane proteins. However, in our reductionist fibroblast expression system, we found that cldn strand patches orient along actin strands only when they can interact with ZO-1. This is the first direct demonstration of the ability of ZO-1 to act as a scaffold linking cldns and actin.

Superresolution colocalization of ZO-1 and actin shows a complete overlay of the two proteins, whereas the continuous GFP cldn strands elaborate out from these structures. This implies that the cldn strands are only intermittently associated with ZO-1 and actin. Formation of intermittent interactions not only could stabilize the paracellular seal, but it might also allow for flexibility in coupling between the cldns, which must stay continuously coupled between cells to maintain the barrier, and the actin cytoskeleton, which must remodel and deform as cells move against each other in a monolayer. We speculate that limited coupling would also allow maintenance of paracellular barrier function in epithelial cells when the circumferential myosin and actin, and likely the associated scaffolding proteins, reorient, contract, or expand in response to a variety of physiological and pathological stimuli ([@B20]; [@B2]; [@B17]).

The FRAP results in this study are consistent with more dynamic coupling between cldn2 and ZO-1 than between cldn2 and ocln. Unlike ZO-1, ocln was recruited to the cldn2 strands, and this interaction reduced the dynamic FRAP behavior of ocln, similar to what was reported previously ([@B10]; [@B6]). We found that cldn strand networks show continuous rearrangement, breaking, and rejoining, as demonstrated previously ([@B29]), and, unexpectedly, this dynamic behavior is independent of interaction with ZO-1 or actin. Breaks and rejoining happen most often at strand junctions, the sites at which ocln also concentrates. Pulse-chase-pulse experiments demonstrated that these strand junctions are also preferred sites for addition of newly synthesized cldns, suggesting that the structure of the cldn strand at these sites may be less well organized and more dynamic than that in midstrand. It is possible as well that there are unidentified, associated proteins that might promote cldn polymerization and depolymerization; this will be investigated in future studies.

How do these findings translate into tight junction behavior in epithelial cells? Fibroblasts lack many critical tight junction proteins (e.g., tricellulin and JAMs), and even when stably expressing cldns, they do not form the linear, continuous belt-like junctions observed in epithelial cells. However, the similarity between our FRAP results and those described in well-polarized epithelial cells ([@B33]) suggests that the nature of the interactions between the tight junction proteins is shared in the two systems. The independent mobilities of cldns, ZO-1, and actin are consistent with a model for their intermittent interaction. Further, we expect network breaking and reforming to be a feature of normal tight junctions because broken strands and complex meshes are features not only of our cldn strand patches, but also of epithelial junctions visualized in FFEM. The breaking and reforming of the cldn network has been suggested as contributing to epithelial paracellular flux of large compounds (reviewed in [@B1]). It also seems likely that, as we observe in fibroblasts, the strand junction points in epithelia could be sites for new cldn addition.

Given the difficulty in imaging epithelial tight junctions at the resolution possible in fibroblasts, although the present observations made in fibroblasts might not fully capture epithelial tight junction behavior, they provide important insights into the interactions among cldns, ZO-1, actin, and ocln, with implications for epithelial barrier structure, function, and regulation.

MATERIALS AND METHODS
=====================

Cell culture and transfections
------------------------------

Rat 1 Tet-off (R1-R12) cells were obtained from the American Type Culture Collection and maintained at 37°C and 5% CO~2~ in high-glucose DMEM (4.5 g/l), supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (pen-strep). Stable cell lines were made by cotransfecting tagged constructs with pSVZeo (Thermo Fisher) using Lipofectamine 2000 according to the manufacturer's directions; cells were selected with 0.8 mg/ml Zeocin (Invivogen) for 14 d, and clonal lines were isolated and analyzed by immunoblot and immunofluorescence. Stable knockout cell lines were made by transfecting pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene 62988; [@B25]) using Lipofectamine 2000. Individual clones were isolated after initial selection for 48 h in 2 µg/ml puromycin (Life Technologies), followed by dilution cloning to single cells into 96-well plates. Clonal lines were expanded and tested 2--3 wk after transfection by immunoblot.

HEK293 cells (Tet-off advanced; Takara) were maintained in high-glucose DMEM supplemented with 10% Tet-qualified FBS (Atlanta Biologicals) and pen-strep. FuGENE transfection reagent (Promega) was used for transfection of GFP- and myc-tagged constructs according to the manufacturer's instructions; cells were collected 48 h after transfection and samples processed for immunoprecipitation experiments as described later.

In some experiments, cells were pretreated for 2 h before imaging with the Rho kinase inhibitor Y27632 (30 μM; Sigma-Aldrich), the Arp2/3 inhibitor CK666 (100 μM; Sigma-Aldrich), or S-nitro-blebbistatin (100 μM, Cayman Chemical).

DNA constructs
--------------

Sequences for all oligonucleotide primers used for cloning are shown in Supplemental Table S1. GFP cldn2 was constructed by cloning mouse cldn2 ([@B5]) into enhanced GFP (EGFP) C3 vector (Takara) using *Eco*RI/*Sal*I. GFP cldn2(−3) was made from the GFP cldn2 using site-directed mutagenesis (Agilent Technologies) to introduce a stop after amino acid 227. GFP linker cldn2 was generated by site-directed mutagenesis (Agilent Technologies). GFP Linker cldn2 Y224E was made from this plasmid also using site-directed mutagenesis (Agilent Technologies). mCherry cldn2 was generated by excising EGFP from GFP cldn2 and replacing it with mCherry (Takara). SNAP-tagged cldn2 was made by infusion cloning after PCR of cldn2 into the *Bam*HI/*Xho*I sites in pSNAPf (New England Biolabs). GFP ZO-1 ([@B8]), myc-tagged ZNA ([@B26]), and GFP occludin ([@B38]) have been previously described. Halo occludin was made by subcloning full-length occludin into pHalo C1 (kindly provided by John Hammer, National Institutes of Health, Bethesda, MD) into the *Nhe*I/*Sal*I sites. GFP cldn1 and cldn11 were made by direct cloning from previously described pTRE constructs ([@B36]) into the *Eco*RI site of the EGFP N1 vector (Takara). TdTomato F-tractin was kindly provided by Robert Fischer (National Institutes of Health; [@B41]).

Stable ZO-1, ZO-2, and double-knockout clones were made using the CRISPR/Cas9 system ([@B25]); two separate vectors targeting different exons were designed for both ZO-1 and ZO-2. Oligonucleotides were phosphorylated, annealed, and cloned into the *Bbs*I site of pSpCas9(BB)-2A-Puro vector according to the Zhang laboratory protocols (MIT).

All constructs were verified by sequencing.

Antibodies
----------

Mouse anti--ZO-1 (33-9100) and rabbit ZO-2 (38-9100) antibodies were from GE Healthcare, mouse Myc-Tag (9B11) antibody was from Cell Signaling Technology, rabbit anti-GFP (Ab290) and rabbit anti--N-cadherin (Ab76057) antibodies were from Abcam, and rabbit anti--β-catenin (C2206) antibody was from Sigma-Aldrich. Antibodies were validated by recognizing bands of the predicted size on immunoblots and by cellular immunolocalization where previously reported. Species-specific secondary antibodies for immunofluorescence (Cy2, Cy3, and Cy5 conjugated) and immunoblots (IR-labeled 680 and 790/800 antibodies) were from Jackson ImmunoResearch. Rhodamine phalloidin and Alexa Fluor 647 phalloidin were from GE Healthcare. Halo ocln was labeled using Janelia Fluor 646 ([@B12]) at 1:200 in cell culture media plus serum, followed by four 10-min washes to allow free dye to diffuse out. Cells were otherwise fixed and stained normally.

Immunofluorescence microscopy
-----------------------------

Rat-1 cells were cultured on uncoated glass coverslips, fixed with 1 or 4% paraformaldehyde in CSK buffer (10 mM 1,4-piperazinediethanesulfonic acid, pH 6.8, 100 mM KCl, 300 mM sucrose, 2 mM MgCl~2~, and 2 mM ethylene glycol tetraacetic acid) at room temperature for 20 min, permeabilized with 0.2% Triton X-100 for 10 min, quenched with 50 mM NH~4~Cl, and incubated in 2% normal goat serum in phosphate-buffered saline (PBS) for 60 min and in primary antibodies for 60 min. After washing, samples were incubated with fluorescent-labeled secondary antibodies; in some cases, rhodamine or Alexa Fluor 647--phalloidin was added with the secondary antibodies. In some cases, cells were fixed with 100% cold ethanol, washed twice with Dulbecco's PBS, and blocked and incubated in primary and secondary antibodies as described. After washing, samples were mounted with Mowiol containing 1% *n*-propyl gallate. Fixed samples were imaged on a Zeiss 710 2P Confocal microscope, using either 20×/numerical aperture (NA) 0.8 air or 63×/NA 1.4 oil objectives with 488-, 561-, and 633-nm laser lines or a Zeiss LSM 880 Airyscan in superresolution mode with a 63×/NA 1.4 objective. Raw data were processed using Airyscan processing with "auto strength" (mean strength ± SD = 5.5 ± 1.3) with Zen Black software, version 2.3

Superresolution images were taken using a GE OMX Blaze V4 Ultrafast Structured Illumination Microscope equipped with four scientific complementary metal-oxide semiconductor cameras using a 60×/1.42 NA lens using 488-, 561-, and 647-nm laser lines. Images were acquired using DeltaVision OMX software. For live-cell imaging, normal medium was supplemented with 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4. Images were taken every 10--15 s for 10 min. Movies are maximum intensity projections of 0.8- to 1.2-μm stacks through the claudin strand patches. FRAP was performed on a Zeiss 780 confocal microscope using a 63x/NA 1.4 oil objective and heated stage in 5% CO~2~. Bleaching of GFP signal was done with the 405-nm laser line (100% power for \<10 s) in a defined region of interest. Subsequent images were taken at the same focal plane to monitor recovery of fluorescence; images were analyzed using ImageJ (National Institutes of Health, Bethesda, MD). Intensity measurements from flanking unbleached membrane regions were used as controls for background intensity changes with time. Subsequent analyses of recovery kinetics were performed using GraphPad Prism.

Contrast and colors were adjusted and figures made using Photoshop CS5.

Pull-down assays and immunoblotting
-----------------------------------

To test interactions between ZO-1 and cldn2 constructs, HEK293 tet-off cells were transfected with inducible myc-tagged ZO-1 N-terminal constructs (amino acids 1--887; ZNA) containing all three PDZ domains ([@B26]). HEK cells were also transfected with GFP alone, GFP cldn2, GFP cldn2(−3), or GFP Linker cldn2. Cells expressing myc-tagged and GFP-labeled constructs were lysed in 1% Triton X-100, 20 mM Tris, pH 7.5, 150 mM NaCl, and 1 mM EDTA with protease inhibitors. Insoluble material pelleted at 12,000 × *g* for 20 min, and supernatants were bound to GFP-trap beads (Chromotek) for 60 min at 4°C. Supernatant (precleared sample) from cells expressing myc-tagged ZNA was saved. GFP beads were washed and then incubated overnight at 4°C with precleared cell lysate from ZO-1--expressing cells as indicated. Beads were washed four times as before, and proteins were eluted with SDS sample buffer and subjected to SDS-gel electrophoresis, transfer, and immunoblot with GFP and myc antibodies.

Pulse-chase-pulse experiments
-----------------------------

Rat-1 cells stably expressing SNAP-tagged cldn2 cultured on glass coverslips were incubated with 3 μM SNAP-Cell TMR-star (all SNAP-cell reagents from New England Biolabs) for 30 min in medium and rinsed three times, and then SNAP-Cell block (10 μM) was added for 30 min. Cells were again washed three times and incubated for various periods of time (2--8 h) before addition of SNAP-Cell 647 SiR and incubation for 30 min. Cells were again washed and incubated for an additional 30 min before fixation with cold ethanol, rinsed, and mounted with Mowiol. In some experiments, SNAP-Cell fluors were reversed.

Statistical analyses
--------------------

All comparisons with three or more conditions were compared by one-way analysis of variance, followed by Tukey's or Dunnett's tests. Comparison of two conditions was performed using Student's *t* test. *p* \< 0.05 was set as the level for significant difference between groups. Statistics was performed using GraphPad Prism 6.
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